CancerFax

Incidence of rectal cancer among young people

Sai SreeWritten by Sai SreeMedically ReviewedUpdated May 8, 20204 min read
Incidence of rectal cancer among young people
In this article
  1. Rising Incidence of Colorectal Cancer in Young Adults
  2. Factors that reduce the risk of colorectal cancer:
  3. Factors that increase the risk of colorectal cancer:
  4. How CancerFax Helps

Rising Incidence of Colorectal Cancer in Young Adults

In 2017, a study published in the Journal of the National Cancer Institute stated that among young people aged 20-50 years, the incidence of rectal cancer is increasing. The institute used SEER registration data from the National Cancer Institute for over 35 years. In addition, the researchers also predict that by 2030, the incidence of colon cancer and rectal cancer will increase by 90% and 124% among adults aged 20-34! The number of people between the ages of 35 and 49 will increase less, 28% and 46% respectively.

In the past two decades, although the increase in obesity and meat consumption has been associated with an increased risk of developing colorectal cancer, reports of newly developing colon and rectal cancer show an average annual decrease of about 2.7%. Smoking is another factor that increases the risk of precancerous polyps and colorectal cancer. Although the proportion of smokers fell from 21% in 2005 to 17% in 2014, according to the Centers for Disease Control and Prevention, it is believed that the majority of colorectal cancer risk reduction is due to improved screening and monitoring of patient risk.

For individuals, knowledge is the key. It is important to pay attention to your health. It is important to understand the family history of rectal cancer and other cancers as much as possible. In addition, we must minimize the factors that may increase the risk of colorectal cancer, such as excessive obesity, red meat consumption, processed foods, and smoking.

Factors that reduce the risk of colorectal cancer:

  • Dietary fiber: Previous evidence shows that dietary fiber can reduce the risk of colorectal cancer, and this report is further supplemented by reporting that 90 grams of whole grains per day can reduce the risk of colorectal cancer by 17%.
  • Whole grains: For the first time, the AICR / WCRF study independently linked whole grains and colorectal cancer. The intake of whole grains can reduce the risk of colorectal cancer.
  • Exercise: Exercising can reduce the risk of colon cancer (but there is no evidence to reduce the risk of rectal cancer).
  • Others: Limited evidence suggests that fish, foods containing vitamin C (oranges, strawberries, spinach, etc.), multivitamins, calcium, and dairy products can also reduce the risk of colorectal cancer.

Factors that increase the risk of colorectal cancer:

  • Large intake (> 500g per week) of red meat and processed meat, including beef, pork, hot dogs, etc .: Previous studies have shown that red meat and processed meat are associated with cancer risk. In 2015, the International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization (WHO), classified processed meat as a “carcinogenic factor for humans.” In addition, studies of premenopausal women have shown that high intake of red meat can increase the risk of breast cancer.\
  • Drink ≥ 2 kinds of alcoholic beverages (30g alcohol) daily, such as wine or beer.
  • Non-starch vegetables / fruits, foods containing heme iron: When the intake is low, the risk of colorectal cancer is high.
  • Other factors such as overweight, obesity, and height can also increase the risk of colorectal cancer. Many methods of preventing colorectal cancer are important for overall health: maintaining a proper weight, exercising properly, limiting red meat and processed meat, increasing the intake of whole grains and dietary fiber, limiting alcohol to a maximum of two glasses per day, and avoiding or stopping smoking. Is it possible to avoid colorectal cancer by achieving the above points? No one can guarantee 100%. However, at least in the process of cancer prevention, it is clear that different “causes” lead to different “fruits”, you know how to choose.

How CancerFax Helps

CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.

description
Medical Record Review

We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.

verified_user
Eligibility Coordination

We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.

hub
Hospital Communication

We support appointment coordination, document submission, translation, and direct communication with international departments.

flight
Travel & Admission Support

For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.

explore
Treatment & Trial Navigation

If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.

support_agent
End-to-end Coordination

From inquiry through to follow-up, our coordinators provide a single point of contact for the family.

CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.

Sai Sree

About Sai Sree

✓ Reviewed for medical accuracy by the CancerFax review panel.

Medical Disclaimer

This article is for educational purposes only and should not replace medical advice, diagnosis, or treatment from a qualified oncology specialist. Every patient's case is different. Treatment decisions should always be made after a review of complete medical records by the treating medical team.

Treatment availability, eligibility, timelines, and access can change. Any clinical trial participation depends on detailed review and approval by the trial hospital or investigator.